Drug combo marks advance against bladder cancer
A cancer drug duo more than doubled the survival of people battling the most common form of advanced bladder cancer, trial results show.
Mar 11, 2024
0
1
A cancer drug duo more than doubled the survival of people battling the most common form of advanced bladder cancer, trial results show.
Mar 11, 2024
0
1
The first over-the-counter (OTC) birth control pill, Opill, will be available at pharmacies, convenience stores, grocery stores and on the Opill.com website later this month or early April.
Mar 9, 2024
0
0
Pancreatic cancer carries the highest mortality rate of all major cancers and is projected to become the second-leading cause of cancer-related deaths in the United States by 2030. It is especially difficult to treat because ...
Mar 6, 2024
0
1
Many childhood cancers start with a hijacking at the molecular level. A group of abnormal proteins known as fusion proteins aberrantly engages with a collection of proteins that switches genes on and off. As a result, genes ...
Mar 6, 2024
0
60
Colorectal cancer is the third most common cancer worldwide, according to the World Health Organization, and a Kansas State University graduate student is doing research to identify and improve effective colon cancer care.
Mar 5, 2024
0
0
Male breast cancer has distinct alterations in the tumor genome that may suggest potential treatment targets, according to a study by Weill Cornell Medicine investigators. They have conducted the first whole genome sequencing ...
Mar 4, 2024
0
0
There are stark differences between European countries when it comes to both the reimbursement of, and access to, new treatments for patients with early-stage lung cancer. There are also differences in reimbursement times ...
Mar 4, 2024
0
0
An important discovery from the NCI-MATCH precision medicine initiative is published in Clinical Cancer Research.
Mar 4, 2024
0
5
Chimeric antigen receptor (CAR)-T cell therapy is a potent emerging weapon against cancer, altering patients' T cells so they can better find and destroy tumor cells. But CAR-T cell therapy doesn't work well in every cancer—including ...
Mar 1, 2024
0
9
Purdue University researchers have developed a patented therapeutic strategy for Lowe syndrome, an incurable and rare genetic disorder, by repurposing two drugs previously approved by the U.S. Food and Drug Administration ...
Feb 29, 2024
0
0